Keywords: cutaneous leishmaniasis, topical, drug delivery Synopsis Objectives: Pathological disorder can disrupt the barrier integrity of the skin thereby altering the drug delivery from topical formulations to the target site. Cutaneous leishmaniasis is an infection of the dermal layers of the skin, and manifests as a variety of skin lesions from defined nodular forms to plaques and chronic ulcers. The aim of this work was to characterise the physiology and barrier integrity of the Leishmaniainfected BALB/c mouse skin and how they impacted delivery of drugs to the skin.
Introduction
Cutaneous leishmaniasis (CL) is a parasitic disease that mainly affects poor communities in low-and middle-income countries with approximately 10 million people affected. 1 CL is characterized by a variety of clinical symptoms ranging from defined nodular forms to chronic ulcerative lesions. Non-complicated lesions tend to heal spontaneously, a process that can take 3 to 18 months depending on the Leishmania species and host susceptibility factors, and nearly always leave a disfiguring scar. 2 Available treatments such as miltefosine, amphotericin B and pentavalent antimonials are constrained by long treatment courses, parenteral drug administration, toxicity, cost and variable efficacy.
In CL, Leishmania parasites typically reside in macrophages in the dermal layer of the skin. Although most current treatments for leishmaniasis are administered by other routes, for simple CL infected tissue can potentially be reached by topically applied drugs. Topical application is advantageous as it allows local and targeted drug exposure, thereby reducing the potential side effects and the need to carefully monitor the patient when given systemic treatment. Moreover, the ease of application makes it patient-friendly. Several topical formulations have been developed in the past to the point of clinical trials and used to treat CL infections, for example, the aminoglycoside paromomycin sulphate (WR279,397, 3 another paromomycin formulation Leshcutan® (Teva, Israel), and amphotericin B. 4 None of these proved to be entirely satisfactory due to side effects or lack of efficacy. For example local side effects such as burning and irritation of the skin were commonly reported upon application of Leshcutan®. 5, 6 This is due to the presence of 12% methylbenzethonium chloride, a cationic quaternary ammonium compound that facilitates drug permeation into the skin. 7, 8 The success of a topical formulation to treat CL depends on the antileishmanial potency of the active ingredient and the amount of drug that reaches the parasites. 9 Skin disorders can alter barrier integrity resulting in increased or decreased drug delivery from topical formulations to their target site in the skin. [10] [11] [12] So far, drug delivery to diseased skin has mainly focused on non-infectious diseases, for example, psoriasis. In psoriatic plaques a reduced barrier integrity resulted in increased drug permeation compared to healthy skin. 13, 14 Infectious skin diseases caused by pathogens such as herpes, Tinea and Candida albicans have also been found to disrupt the physiology and barrier function of the skin. The barrier integrity in tinea-affected skin, was characterised by reduced stratum corneum hydration, enhanced proliferation and disturbed differentiation of the epidermis compared to healthy skin.
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To date there is no information available on the permeability of Leishmania-infected skin. An understanding of the permeability of skin infected by Leishmania parasites will help the optimisation of drug delivery. Thus, we aimed to characterise the skin barrier function in the early stages of CL in a mouse model with respect to histology, transepidermal water loss (TEWL), skin pH, and the permeability to topically applied compounds. Caffeine and ibuprofen, two model permeants 15, 16 were chosen for study because of their divergent physico-chemical After about 7 days, a small papule at the site of injection was visible in the infected mice. The lesion size was measured daily using callipers.
TEWL, skin pH and hydration were measured every other day as follows: mice were left to acclimatise in the room for 1 hour before being placed in the induction chamber. Anaesthesia were induced at 3% isoflurane with 100% oxygen at a flow rate of 2.5 L/min until no movement was observed and maintained with 2% isoflurane and 100%
oxygen at 2.5 L/min. TEWL was measured using the Aquaflux AF102
(Biox, London), the equipment was calibrated according to the manufacturer's guidelines prior to starting the experiment and was baseline calibrated prior to use each day. Skin hydration was measured using the moisture checker (MY-808S, Scalar, Japan) and the skin-pH was obtained with the Skin-pH-Meter ® PH 905 from CK electronics (Köln, Germany). The mice recovered from anaesthetics on a warm plate (37˚C). Statistical analysis were performed using SPSS software version 19.0.
When the lesion diameter reached 5-6 mm, the mice were sacrificed and the papule was excised for histological examination or permeation studies. For histological evaluation, the samples were collected and fixed in 10% neutral formalin solutions until they were further processed at the UCL Institute of Neurology (Queen Square, London). Images of the processed and stained samples were taken using a Leica DMRB microscope (Leica, Germany) equipped with a Leica DFC 420 camera controlled by Leica Application Suite (version 3.1). For permeation studies, the uninfected control tissue was taken from above the CL nodule on the back of the same donor mouse.
Investigation into permeability of infected vs uninfected skin
Franz cell devices with narrow diameter (5 mm) were produced (Soham Scientific, Fordham, UK) in order to measure the permeation of a drug through a Leishmania infected skin area (5 mm diameter). All drugs were purchased from Sigma Aldrich (Dorset, UK) except for amphotericin B, which was obtained from VWR International (Leicestershire, UK) and 
Drug quantification
HPLC-UV. All compounds, except paromomycin, were analysed using a 1260 Infinity Agilent HPLC system. The column and settings used to separate and detect the compounds are summarised in Table 1 
Results

Histological changes in
Ex vivo permeability of Leishmania-infected skin
The cumulative amount of each test molecule in the receptor compartment of Franz diffusion cells, as a function of time, is shown in Figure 4 and permeation derived parameters such as lag time, flux and permeability coefficients are shown in Table 2 .
Infected skin was more permeable to the model molecules compared to uninfected skin. Both caffeine and ibuprofen, applied as a saturated solutions, showed a higher permeation through infected skin compared to uninfected skin. At the end of the 48-hour experiment, the cumulative amount of caffeine that had permeated through infected skin was 2 to 47 times higher compared to uninfected skin (t-test, p < 0.05), the flux was 66 times higher and the permeability coefficient was 50 times higher for infected skin compared to uninfected skin (p<0.05). For ibuprofen, the corresponding differences between infected and uninfected skin were more modest, although they were still statistically significant. After 48 hours of permeation, the cumulative amount of permeated ibuprofen was 2 to 3 times higher while the flux and permeability coefficient were twice as high for the infected skin compared to the uninfected skin (t-test, p<0.05). Interestingly, for both caffeine and ibuprofen, there was no difference in lag times for infected an uninfected skin (t-test, p >0.05).
For the anti-leishmanial drugs, uninfected skin was impermeable to the test compounds and no drugs could be detected in the receptor phase throughout the 48-hour permeation experiment. In contrast, the permeability of infected skin depended on the drug, being impermeable to amphotericin B, slightly permeable to buparvaquone, and highly permeable to paromomycin.
When the permeation profiles and parameters of all the tested compounds through infected skin are compared, paromomycin sulphate had the highest flux compared to caffeine, ibuprofen and buparvaquone (one-way ANOVA, p<0.05) while buparvaquone had the highest lag time and permeability coefficient compared to paromomycin, caffeine and ibuprofen (p >0.05 for both lag time and Kp).
Discussion
A number of approaches were used to characterise skin barrier integrity, an important parameter that influences topical drug delivery to Leishmania-infected skin. We first examined the histopathological changes in skin physiology. The most outstanding observation was the ingress of abundant inflammatory cells to the place of infection which disturbed the continuity of the epidermal and dermal skin layers. This is similar to previous reports of inflammation in BALB/c mice that are highly susceptible to Leishmania major infection, and where lesions are characterised by extensive inflammation, ulceration and necrosis.
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The disturbance to the epidermal and dermal skin layers, shown by the reduced density of the collagen and epidermal hyperplasia, indicates that the skin barrier properties may be reduced; abnormalities in the epidermal layer such as proliferation and differentiation being known to be essential for the integrity of the skin barrier function. 22 Indeed, reduced skin barrier properties were observed. TEWL -an indication of how well the skin controls water movement from the interior of the body -was doubled in Leishmania-infected skin. Such increase in TEWL was also observed in a number of other skin diseases such as tinea infections, psoriasis. 11, 23, 24 Interestingly, the skin hydration, measured by the moisture sensor, did not change upon infection. This was surprising as inflammation in the infected lesion and the subsequent oedema was expected to increase the water content in the skin. Our results may be explained by the fact that the moisture sensor only measures the moisture content of the stratum corneum, 25 and not that of the whole skin. It appears that despite fluid accumulation in the Leishmania lesion, the surface of the skin does not become more hydrated compared to uninfected skin.
Uninfected mouse skin had an acidic surface, correlating with the "acid mantle" term used to describe the inherent acidic nature of the stratum corneum, 26 and the pH value of 5.8 is similar to previously reported value of 5.9 for hairless mouse skin. 27 Skin surface pH is known to be influenced by certain diseases, for example, tinea infection in humans resulted in a higher foot skin pH. 28 The absence of any difference in the pH of Leishmania-infected and uninfected skin could be due to the fact that Leishmania infection was not located in the stratum corneum.
Instead, as shown in Figure 2E , the L. major amastigotes were present in the dermis.
The reduced barrier function of Leishmania-infected skin indicated by TEWL (as discussed above) was confirmed in permeation experiments.
However, the permeant's size and lipophilicity play a critical role in its permeation (or lack of). The hydrophilic molecules paromomycin sulphate and caffeine showed much larger increases in flux compared to the more lipophilic molecules ibuprofen and buparvaquone through infected skin. The presence of Leishmania parasites in the skin triggers a cascade of reactions resulting in inflammation and release of chemokines. 29, 30 It seems that the subsequent oedema, caused by additional fluid accumulating in the interstitial spaces, facilitates permeation of the more water soluble compounds such as caffeine and paromomycin sulphate while the permeation of drugs with low water solubility such as buparvaquone was not increased to the same extent.
Another possible reason for the enhanced permeation of the water soluble compounds could be the greater concentration gradient from donor to receptor phases for compounds with a higher aqueous solubility.
All the permeants were applied as saturated solutions and therefore had a thermodynamic activity of 1. The rate of diffusion of molecules through a membrane is proportional to the concentration gradient. For the highly -water soluble paromomycin sulfate, this gradient is nearly 25 times higher compared to caffeine and more than 4000 times higher compared to ibuprofen. This is likely to contribute to this increased permeation for more water soluble compounds.
In contrast to paromomycin, buparvaquone's flux through infected skin is hampered by its low water solubility and it's high lipophilicity, as suggested for healthy skin. 17 Low water solubility means low drug concentration in the donor phase and hence low concentration gradient across the skin, while drugs with a high lipophilicity means that the drug is able to quickly partition into the lipid component of the stratum corneum and remains there preferentially, such that a very long lag time and low flux through the damaged infected skin is observed.
As mentioned above, permeant size was also critical to its flux through a faster healing rate compared to placebo except for one lesion. 37 In this case, the major reason for lesion healing caused by amphotericin B would be the absence of the stratum corneum in CL ulcers, i.e the absence of any barrier to the topically-applied drug from its site of action.
In addition, amphotericin B, paromomycin and buparvaquone were also unable to permeate through healthy uninfected skin. Paromomcyin also has a high molecular weight and physicochemical properties that are unfavourable for skin permeation. This was reflected in the lack of permeation through uninfected skin in our study, as described previously The inter-individual variability in our permeation profiles (Figure 4 ) was high. Similar variability, has been reported in previous clinical studies [40] [41] [42] and was ascribed to differences in skin lipid composition and stratum corneum thickness between the test subjects. In this study inbred BALB/ mice were used to mitigate inter-individual variability. However, possible changes caused experimental manipulations as suggested by 43, 44 could not be avoided. Moreover, the permeation experiments which were conducted on infected skin, included variations in the progression of the infection in individual mice, despite the use of a standardised inoculum of L. major parasites to create lesions.
Despite the variability, we found a greater permeability of Leishmaniainfected skin and the influence of the permeant's molecular mass and water-solubility/hydrophilicity was established. The importance of this data in relation to treatment of clinical CL is at present unclear due to known differences in mouse and human skin, including (i) the thinner mouse skin and mouse stratum corneum, 45 (ii) the absence of sweat glands in mouse skin, and (iii) the higher number of hair follicles in mouse skin and (iv) the different composition of intercellular stratum corneum lipids 46 which can all contribute to the higher permeability of mouse skin. [47] [48] [49] Further studies on human skin are required to determine whether these alterations in mouse skin are predictive of similar changes in human skin. This is important in relation to both the potential of new anti-leishmanial drugs in topical formulations, and an approach towards the direct administration of topical formulations on intact skin over CL nodules or around CL ulcers, where the infection is found in the dermis, which should avoid the need for removal of the ulcerative crust, washing and occlusion. 
